Home › Funds › Zuckerman Investment Group, LLC › ABT

Zuckerman Investment Group, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Zuckerman Investment Group, LLC reported holding 122,584 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 0.94% of its reported portfolio and ranking #36 among its reported holdings. Zuckerman Investment Group, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)122.58K sh
Reported value held$11.12M
Portfolio Weight0.94%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Zuckerman Investment Group, LLC's ABT position evolved

Zuckerman Investment Group, LLC first disclosed a stake in ABT in Q3 2023 at 69,356 shares (US$6.7M). The position peaked in Q4 2025 at 122,175 shares, worth US$15.3M. Across 12 filings, Zuckerman Investment Group, LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 122,584 shares valued at US$11.1M — a reduction of -1,217 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2025 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 69.36K $6.72M New
Q4 2023 69.25K $7.62M Hold
Q1 2024 72.27K $8.21M Add
Q2 2024 72.33K $7.52M Hold
Q3 2024 72.93K $8.32M Add
Q4 2024 72.91K $9.37M Hold
Q1 2025 72.75K $9.65M Hold
Q2 2025 72.75K $9.89M Hold
Q3 2025 78.32K $10.49M Add
Q4 2025 122.17K $15.31M Add
Q1 2026 123.80K $12.71M Add
Q2 2026 122.58K $11.12M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Zuckerman Investment Group, LLC held ABT?

Zuckerman Investment Group, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Zuckerman Investment Group, LLC's current position in ABT?

As of Q2 2026, Zuckerman Investment Group, LLC holds 122.58K shares of ABT (ABBOTT LABORATORIES), valued at $11.12M, representing 0.94% of its reported portfolio and ranking #36.

Has Zuckerman Investment Group, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Zuckerman Investment Group, LLC reduced its position in ABT. The position peaked in Q4 2025 at 122.17K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.